Every lot published · search any lot number before you order

Heart Rate in the Retatrutide Phase 2 Obesity Trial

The Phase 2 obesity publication described dose-dependent increases in heart rate that peaked at 24 weeks and declined later. The result is one of several safety observations reported by investigators.

Heart Rate in the Retatrutide Phase 2 Obesity Trial. A monitored safety measure. Study design, Measure, Interpretation. GLP LIFE SCIENCES · RESEARCH BRIEF 43 A monitored safety measure Safety and methods Study designMeasureInterpretation
A monitored safety measure. Illustration for this research brief.

A monitored safety measure

A change in heart rate and a cardiovascular outcome such as a heart attack are different endpoints. A trial designed around weight change may not be sized or followed long enough to measure major cardiovascular outcomes precisely.

How to interpret the evidence

Use the safety table for the observed signal and look for a dedicated outcomes trial when the question involves clinical cardiovascular events.

This research summary focuses on a defined endpoint or safety observation. Its relevance depends on the study’s population and follow-up.

Sources